# Todd Schonherz

> Todd Schonherz is the Fort Myers-based chief executive officer and a board member of American Oncology Network. His career spans software and information systems, operating leadership at Florida Cancer Specialists, and AON leadership from its early development through a Nasdaq debut, a subsequent move to OTCQX, and an acquisition agreement announced by Cencora in October 2026.

- **Role:** Chief Executive Officer and Board Member at American Oncology Network
- **Organizations:** American Oncology Network, Florida Cancer Specialists & Research Institute, US Oncology, Datamedic Corporation, Multum Corporation, MedE America, CanCare
- **Education:** Bachelor’s degree in health policy and administration, Pennsylvania State University
- **Known for:** EY Entrepreneur Of The Year 2023 Florida Award finalist., Official biography credits him with InformationWeek 500 recognition and a ComputerWorld/IDG Laureate Award during his US Oncology tenure., Led AON as chief executive through its September 2023 business combination and public trading debut.

## Career timeline

- **Before 1999** — Consulting and management experience included Datamedic Corporation, Multum Corporation, and MedE America; exact appointment dates are not established.
- **1999-2010** — US Oncology tenure included senior vice president and chief information officer; also held director of enterprise applications and vice president of information systems roles.
- **2011** — Became chief operating officer of Florida Cancer Specialists.
- **2017** — Served as AON chief operating officer during the organization’s early development; AON publicly launched in 2018.
- **2020-01-27** — Appointed president and chief operating officer of AON.
- **2021-04-01** — Became AON chief executive officer, succeeding Brad Prechtl.
- **2023-05** — Named an EY Entrepreneur Of The Year Florida Award finalist.
- **2023-09-21** — Rang Nasdaq’s closing bell to mark AON’s public trading debut following its business combination.
- **2024-06-10** — AON began OTCQX trading after announcing a voluntary Nasdaq delisting.
- **2026-10-21** — Cencora announced a definitive agreement to acquire AON; the transaction remained subject to approvals and closing conditions.

## Achievements

- EY Entrepreneur Of The Year 2023 Florida Award finalist.
- Official biography credits him with InformationWeek 500 recognition and a ComputerWorld/IDG Laureate Award during his US Oncology tenure.
- Led AON as chief executive through its September 2023 business combination and public trading debut.

## Latest updates

- **2026-10** — Cencora announced a definitive agreement to acquire AON on October 21. Approvals and customary closing conditions were still required.
- **2025-05** — AON appointed Joe Verschleiser chief growth and performance officer, with Schonherz emphasizing growth and operational improvement.
- **2024-06** — AON appointed David Afshar chief financial and operating officer and began OTCQX trading.

## Links

- Website: https://www.aoncology.com/leadership/
- LinkedIn: https://www.linkedin.com/in/todd-schonherz-b28163

---

Profile page: https://yespress.io/todd-schonherz
Published by YesPress — https://yespress.io
Last updated: 2026-10-22